These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 30636542)

  • 1. Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension.
    Tu L; Desroches-Castan A; Mallet C; Guyon L; Cumont A; Phan C; Robert F; Thuillet R; Bordenave J; Sekine A; Huertas A; Ritvos O; Savale L; Feige JJ; Humbert M; Bailly S; Guignabert C
    Circ Res; 2019 Mar; 124(6):846-855. PubMed ID: 30636542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial
    Theilmann AL; Hawke LG; Hilton LR; Whitford MKM; Cole DV; Mackeil JL; Dunham-Snary KJ; Mewburn J; James PD; Maurice DH; Archer SL; Ormiston ML
    Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2605-2618. PubMed ID: 32998516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
    Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
    Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
    Upton PD; Davies RJ; Trembath RC; Morrell NW
    J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10.
    Bouvard C; Tu L; Rossi M; Desroches-Castan A; Berrebeh N; Helfer E; Roelants C; Liu H; Ouarné M; Chaumontel N; Mallet C; Battail C; Bikfalvi A; Humbert M; Savale L; Daubon T; Perret P; Tillet E; Guignabert C; Bailly S
    Cardiovasc Res; 2022 Jun; 118(7):1805-1820. PubMed ID: 34086873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Modulating BMP9, BMPR2, and AQP1 on BMP Signaling in Human Pulmonary Microvascular Endothelial Cells.
    Lotsios NS; Keskinidou C; Dimopoulou I; Kotanidou A; Langleben D; Orfanos SE; Vassiliou AG
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the ALK1 ligands, BMP9 and BMP10.
    Li W; Salmon RM; Jiang H; Morrell NW
    Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP9 and BMP10 Act Directly on Vascular Smooth Muscle Cells for Generation and Maintenance of the Contractile State.
    Wang L; Rice M; Swist S; Kubin T; Wu F; Wang S; Kraut S; Weissmann N; Böttger T; Wheeler M; Schneider A; Braun T
    Circulation; 2021 Apr; 143(14):1394-1410. PubMed ID: 33334130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells.
    Wang J; Liu W; Lu W; Luo X; Lin Y; Liu S; Qian J; Zhang C; Chen H; Li Y; Li X; Chen J; Chen Y; Jiang Q; Liu C; Hong C; Wang T; Tang H; Zhong N; Yang J; Yang K; Sun D
    Biochem Pharmacol; 2022 May; 199():114986. PubMed ID: 35276216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone Morphogenetic Protein 9 Protects against Neonatal Hyperoxia-Induced Impairment of Alveolarization and Pulmonary Inflammation.
    Chen X; Orriols M; Walther FJ; Laghmani EH; Hoogeboom AM; Hogen-Esch ACB; Hiemstra PS; Folkerts G; Goumans MTH; Ten Dijke P; Morrell NW; Wagenaar GTM
    Front Physiol; 2017; 8():486. PubMed ID: 28751863
    [No Abstract]   [Full Text] [Related]  

  • 11. Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension.
    Long L; Ormiston ML; Yang X; Southwood M; Gräf S; Machado RD; Mueller M; Kinzel B; Yung LM; Wilkinson JM; Moore SD; Drake KM; Aldred MA; Yu PB; Upton PD; Morrell NW
    Nat Med; 2015 Jul; 21(7):777-85. PubMed ID: 26076038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.
    Nickel NP; Spiekerkoetter E; Gu M; Li CG; Li H; Kaschwich M; Diebold I; Hennigs JK; Kim KY; Miyagawa K; Wang L; Cao A; Sa S; Jiang X; Stockstill RW; Nicolls MR; Zamanian RT; Bland RD; Rabinovitch M
    Am J Respir Crit Care Med; 2015 Jun; 191(11):1273-86. PubMed ID: 25853696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of heterozygous ALK1 mutations on the transcriptomic response to BMP9 and BMP10 in endothelial cells from hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension donors.
    Al Tabosh T; Liu H; Koça D; Al Tarrass M; Tu L; Giraud S; Delagrange L; Beaudoin M; Rivière S; Grobost V; Rondeau-Lutz M; Dupuis O; Ricard N; Tillet E; Machillot P; Salomon A; Picart C; Battail C; Dupuis-Girod S; Guignabert C; Desroches-Castan A; Bailly S
    Angiogenesis; 2024 May; 27(2):211-227. PubMed ID: 38294582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability.
    Akla N; Viallard C; Popovic N; Lora Gil C; Sapieha P; Larrivée B
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1821-1836. PubMed ID: 29880487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension.
    Yung LM; Nikolic I; Paskin-Flerlage SD; Pearsall RS; Kumar R; Yu PB
    Am J Respir Crit Care Med; 2016 Nov; 194(9):1140-1151. PubMed ID: 27115515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer.
    Ouarné M; Bouvard C; Boneva G; Mallet C; Ribeiro J; Desroches-Castan A; Soleilhac E; Tillet E; Peyruchaud O; Bailly S
    J Exp Clin Cancer Res; 2018 Aug; 37(1):209. PubMed ID: 30165893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats.
    Jiang Q; Liu C; Liu S; Lu W; Li Y; Luo X; Ma R; Zhang C; Chen H; Chen Y; Zhang Z; Hong C; Guo W; Wang T; Yang K; Wang J
    Br J Pharmacol; 2021 Jan; 178(1):203-216. PubMed ID: 33080042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YC-1 attenuates hypoxia-induced pulmonary arterial hypertension in mice.
    Huh JW; Kim SY; Lee JH; Lee YS
    Pulm Pharmacol Ther; 2011 Dec; 24(6):638-46. PubMed ID: 21963997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
    Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
    J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone Morphogenetic Protein 9 Is a Paracrine Factor Controlling Liver Sinusoidal Endothelial Cell Fenestration and Protecting Against Hepatic Fibrosis.
    Desroches-Castan A; Tillet E; Ricard N; Ouarné M; Mallet C; Belmudes L; Couté Y; Boillot O; Scoazec JY; Bailly S; Feige JJ
    Hepatology; 2019 Oct; 70(4):1392-1408. PubMed ID: 30964206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.